Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
Add filters

Document Type
Year range
1.
2nd International Conference on Biological Engineering and Medical Science, ICBioMed 2022 ; 12611, 2023.
Article in English | Scopus | ID: covidwho-2323057

ABSTRACT

The year 2019 ended with the official report of an unknown pneumonia outbreak in Wuhan, Hubei Province, China. Subsequently, this novel pneumonia was named COVID-19, which mainly attacks the respiratory system, causing severe damage. Although vaccination has relieved the stress of combating pandemics around the world after one year, there are still unknowns and challenges that come with hope. In this regard, stem cell therapy has been proposed as an effective approach to treating COVID-19. Mesenchymal stem cells (MSCs) can potentially be used as a hopeful tool in the cell-based therapy due to their ability to regenerate and regulate immune response. Although research and clinical results have shown encouraging achievement in patients who were treated with MSCs, drawbacks and challenges still exist in the face of new opportunities. This review aims to introduce the challenges of the COVID-19 vaccine and the possible clinical use of MSC-based therapy. Through analysis of COVID-19 and MSC-based therapy, the author aims to find the possibilities and feasibility of using MSCs to treat acute respiratory diseases, such as COVID. As a result, the author finds that MSC treatment is very practical, and it shows significant potential to treat COVID-19. © 2023 SPIE.

2.
Sustainable Cities and Society ; 88, 2023.
Article in English | Web of Science | ID: covidwho-2308418
3.
IEEE Internet of Things Journal ; : 1-1, 2023.
Article in English | Scopus | ID: covidwho-2294973
5.
Zhonghua Xin Xue Guan Bing Za Zhi ; 49(12): 1261-1266, 2021 Dec 24.
Article in Chinese | MEDLINE | ID: covidwho-2288152
7.
Emerging Markets Review ; 55, 2023.
Article in English | Scopus | ID: covidwho-2258971
8.
Information Technology and People ; 2023.
Article in English | Scopus | ID: covidwho-2269796
9.
J Endocrinol Invest ; 2022 Oct 28.
Article in English | MEDLINE | ID: covidwho-2288539

ABSTRACT

PURPOSE: Studies have found that erectile dysfunction (ED) may be a short-term or long-term complication in coronavirus disease 2019 (COVID-19) patients, but no relevant studies have completed a pooled analysis of this claim. The purpose of the review was to comprehensively search the relevant literature, summarize the prevalence of ED in COVID-19 patients, assess risk factors for its development, and explore the effect of the COVID-19 infection on erectile function. METHODS: Medline, Embase, and the Cochrane Library was performed from database inception until April 14, 2022. Heterogeneity was analyzed by χ2 tests and I2 was used as a quantitative test of heterogeneity. Subgroup analyses, meta-regression, and sensitivity analyses were used to analyze sources of heterogeneity. RESULTS: Our review included 8 studies, 4 of which functioned as a control group. There were 250,606 COVID-19 patients (mean age: 31-47.1 years, sample size: 23-246,990). The control group consisted of 10,844,200 individuals (mean age: 32.76-42.4 years, sample size 75-10,836,663). The prevalence of ED was 33% (95% CI 18-47%, I2 = 99.48%) in COVID-19 patients. The prevalence of ED based on the international coding of diseases (ICD-10) was 9% (95% CI 2-19%), which was significantly lower than the prevalence of ED diagnosed based on the International Index of Erectile Function (IIEF-5) (46%, 95% CI 22-71%, I2 = 96.72%). The pooling prevalence of ED was 50% (95% CI 34-67%, I2 = 81.54%) for articles published in 2021, significantly higher than that for articles published in 2022 (17%, 95% CI 7-30%, I2 = 99.55%). The relative risk of developing ED was 2.64 times in COVID-19 patients higher than in non-COVID-19 patients (RR: 2.64, 95% CI 1.01-6.88). The GRADE-pro score showed that the mean incidence of ED events in COVID-19 patients was 1,333/50,606 (2.6%) compared with 52,937/844,200 (0.4%) in controls; the absolute impact of COVID-19 on ED was 656/100,000 (ranging from 4/100,000 to 2352/100,000). Anxiety (OR: 1.13, 95% CI 1.03-1.26, I2 = 0.0%) in COVID-19 patients was a risk factor for ED. CONCLUSION: COVID-19 patients have a high risk and prevalence of ED, mainly driven by anxiety. Attention should be paid to patient's erectile functioning when treating COVID-19.

11.
12.
Journal of Media Ethics: Exploring Questions of Media Morality ; 38(1):60-63, 2023.
Article in English | Scopus | ID: covidwho-2240654
13.
16th ROOMVENT Conference, ROOMVENT 2022 ; 356, 2022.
Article in English | Scopus | ID: covidwho-2237578

ABSTRACT

The airport terminal with high numbers of occupied passengers has potentially become high risk region for aerosol transmission of COVID-19. In this paper, the Eulerian-Lagrangian approach and realizable k-ε turbulence model is used to numerically simulate the airflow organization and aerosol transmission when passengers move slowly in a line. During the aerosol transmission period, evaporation is also enrolled as it is a key factor influencing particle size distribution at the beginning of aerosol transmission from the human. In addition, the process of passenger moving in the airport terminal is realized by employing dynamic mesh algorithms. The results of the study show that people who are behind the infected person during the queuing movement have a higher risk of infection than those who are in front. In addition, the disturbance of people walking has an important influence on the distribution of aerosols. © The Authors, published by EDP Sciences. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/)

14.
16th ROOMVENT Conference, ROOMVENT 2022 ; 356, 2022.
Article in English | Scopus | ID: covidwho-2232505

ABSTRACT

Hospital ward is one of non-negligible potential places to occur cross-infection among patients and health workers. Air-borne transmission was regarded as the main infection route of the SARS-CoV-2. Preventing the air-borne transmission should be a significant measure, which could effectively mitigate the risk of the virus infection. Based on those consideration, in this study, the influence of different types of air distribution on ventilation effectiveness was modeled through Computational Fluid Dynamics (CFD) simulations. Several typical negative pressure wards same as the ward in Wuhan Thunder God Mountain hospital and conformed to the Chinese National Health Commission (NHC) guidelines were modelled. We simulated the influence of different locations of air supply inlets, analysed the influence of the buffer door and compared the contaminant concentration on different entry route for health workers. The results show that the air distribution required by NHC guidelines could retain a directional airflow from the bed-zone to the toilet, which also has a better accessibility of supply air, and health workers are safer to avoid standing closed to the air exhaust outlet in the downstream area of pollutants during ward rounds. © The Authors, published by EDP Sciences. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/)

15.
Advances in Production Engineering & Management ; 17(4):425-438, 2022.
Article in English | ProQuest Central | ID: covidwho-2204004
17.
Journal of Media Ethics ; 2022.
Article in English | Web of Science | ID: covidwho-2187926
19.
20.
International Review of Financial Analysis ; 86, 2023.
Article in English | Scopus | ID: covidwho-2179814
SELECTION OF CITATIONS
SEARCH DETAIL